$5.34
0.122.30%
Last update: May 20, 11:40 AM
Strata Critical Medical Inc Stock Guidance
SRTANASDAQ
Strata Critical Medical (SRTA) last issued guidance on May 6, 2026 for fiscal year 2026. The company guided revenue in the range of $260.00M - $275.00M for the period.
Compared to prior guidance, Strata Critical Medical maintained its revenue forecast from a prior range of $260.00M - $275.00M.
Strata Critical Medical has issued 4 guidance updates between November 10, 2025 and May 6, 2026. During this period, the company raised its outlook 2 times, reflecting management's growing confidence in business performance.
Latest Guidance Date
May 6, 2026
Guidance Period
Full Year 2026
Revenue Guidance Range
$260.00M - $275.00M
Strata Critical Medical Guidance History
Review all historical guidance issued by Strata Critical Medical, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Strata Critical Medical (SRTA)?
The most recent guidance for Strata Critical Medical (SRTA) was reported on May 6, 2026 for the fiscal year 2026. Strata Critical Medical forecasted revenue between $260.00M and $275.00M for the period.
What revenue range did Strata Critical Medical (SRTA) guide for?
Strata Critical Medical (SRTA) guided revenue in the range of $260.00M to $275.00M for the fiscal year 2026.
Did Strata Critical Medical (SRTA) raise or lower guidance?
Strata Critical Medical (SRTA) maintained its revenue guidance from a prior range of $260.00M - $275.00M to $260.00M - $275.00M for the fiscal year 2026.
When did Strata Critical Medical (SRTA) last issue guidance?
Strata Critical Medical (SRTA) last issued guidance on May 6, 2026 for the fiscal year 2026.
